DailyIQ
DailyIQ
Last updated1 minute ago

CL·Colgate-Palmolive Company

$96.94
-1.75 (-1.77%)
High
$98.00
Open
$95.30
Market Cap
78.51B
52W High
$101.18
Low
$95.30
P. Close
$96.94
P/E
38.24
52W Low
$75.96
Fwd P/E
24.07
DailyIQ Est.
$103.45
Inst. Own.
66.8%
Short Interest
2.15%
Days to Cover
3.5
Div. Yield
2.15%
Next Ex-Div
~Jan 20
Div. Growth
51+ yrs
NewEarnings release, scored · filed Oct 30, 2026tone -7.3 vs prior release · 88 lines scoredSee the breakdown
Technical Score (1D)
57
BULLISH
News Sentiment
55
BULLISH
On Nov 5, Colgate‑Palmolive (CL) agreed to pay a $930,000 penalty to the U.S. Environmental Protection Agency for failing to report several imported chemical substances between 2016 and 2019, and the company filed the missing 2020 data and committed to submit a 2024 chemical data report. That same day, CL reported Q1 FY2027 earnings that beat expectations, with core earnings per share rising to $2.00 from the forecasted $1.89 and organic sales growing 4.0% driven by volume increases that helped offset higher input costs linked to rising oil prices. Analysts noted that CL’s pricing strategy mitigated margin erosion from currency fluctuations and a cautious U.S. consumer base, suggesting the dividend can withstand short‑term cost spikes. In addition, analysts highlighted that CL had outperformed the broader market over the past year, viewing the company’s performance as a sign of resilience and growth potential. The positive outlook reflected confidence in the brand’s global reach and steady demand for its consumer products.
LOW TARGET
$88 -9.2%
2 analysts
MEAN TARGET
$102 +4.9%
19 analysts
HIGH TARGET
$112 +15.5%
11 analysts
PRICE RANGE
$88.00 - $112.00
SB / B / H / S / SS
5/15/10/1/1
DAILYIQ EST.
$103.45 (+6.7%)
Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NYQ
Country
United States
Symbol
CL
Description
Colgate-Palmolive is a global consumer goods company focused on two primary segments: Oral, Personal and Home Care, and Pet Nutrition. The company's core business revolves around the manufacturing and distribution of a wide array of well-known brands, including Colgate, Palmolive, and Hill's Science Diet. Its Oral, Personal and Home Care segment offers a diverse portfolio of essential products, from toothpaste and soap to household cleaners, sold through various retail channels, including online platforms. Complementing this, the Pet Nutrition division provides nutritional products for pets, catering to both everyday needs and therapeutic requirements, distributed through pet supply retailers and veterinary professionals. Founded in 1806, Colgate-Palmolive maintains a strong presence in the consumer market, offering established brands and a broad distribution network.
Bought (1Y)
0 shares
$0
Sold (1Y)
385,826 shares
$35.4M
BILBREY JOHN P-
Award/Grant271 shares2026-10-01
Newman Brian-
Award/Grant214 shares2026-10-01
NORRINGTON LORRIE M-
Award/Grant300 shares2026-10-01
Malcolm GregoryEVP and Controller
Award/Grant7,477 shares2026-09-16
Malcolm GregoryEVP and Controller
Award/Grant1,081 shares2026-09-16
60/ 100
Neutral / mixed
Overall: Neutral
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
60.1%
Net Margin
10.5%
Revenue CAGR
2.2%
Current Ratio
0.83x
Debt / Equity
147.89x
Return on Equity
3948.1%
Earnings Summary
In the most recent quarters, Colgate‑Palmolive continued to deliver solid earnings, with Q1‑2026 EPS of $0.97 beating the $0.9566 estimate and Q2‑2026 EPS of $0.99 surpassing the $0.94709 forecast; revenue in both quarters, however, fell short of expectations, reporting $5.32 billion versus $5.33 billion and $5.36 billion versus $5.52 billion respectively. This pattern of EPS outperformance coupled with modest revenue shortfalls has persisted over the last four quarters, with the company consistently beating earnings estimates in each period while revenue growth has decelerated from the $5.13 billion Q3‑2025 level to $5.36 billion in Q2‑2026. Historically, the firm has maintained a positive YoY revenue trajectory, with organic sales growth in four of five divisions reported in Q3‑2026, and has frequently outperformed analyst expectations on earnings, even when revenue growth has been uneven. Recent news highlights a strategic focus on international expansion and margin improvement: the company announced a $2.2 billion shareholder return, a 7% free‑cash‑flow increase year‑to‑date, and a shift toward a data‑driven U.S. go‑to‑market model, all of which reinforce its earnings resilience.

EPS

EstBeatMiss
$0.87$0.91$0.94$0.97$1.01Q3'25Q4'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$0.99 - -
Q3'26$0.95$0.97+1.7%
Q2'26$0.95$0.99+4.5%
Q1'26$0.96$0.97+1.4%
Q4'25$0.94$0.95+1.1%
Q3'25$0.89$0.91+2.4%

Revenue

EstBeatMiss
$5.1B$5.2B$5.3B$5.5B$5.6BQ3'25Q4'25Q1'26Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$5.5B - -
Q3'26$5.5B$5.4B-2.3%
Q2'26$5.5B$5.4B-2.9%
Q1'26$5.3B$5.3B-0.2%
Q4'25$5.3B$5.2B-0.8%
Q3'25 - $5.1B -

Market Data

CL Stock Snapshot

NEUTRAL57/100
$96.94−$1.75 (1.8%)
Market cap
78.51B
P/E ratio
38.2
Day range
$95.30 – $98.00
News sentiment
55/100 · Neutral
Analyst target
$101.70 (+4.9%)
Consensus
Buy · 32 analysts
52-week range+27.6% off low · -4.2% from high
$75.96$101.18
Price $96.94 DailyIQ Est. $103.45

CL is in a holding pattern - neither trend nor momentum has taken control. Earnings and guidance carry more weight than macro data at this capitalisation.

Reverse DCF

What growth is priced into CL?

CHEAP

At today's price, Colgate-Palmolive Company needs to grow free cash flow about -0.6% a year for 3 years, slowing to a long-run rate by year 10, to justify its valuation at a 6.00% cost of capital. Over the last five years its revenue has trended at 4.3% a year, so the market is asking for 4.9 percentage points below its own delivered rate. On that basis CL looks priced below what its own growth record supports.

Implied FCF growth
-0.6%
Growth trend
4.3%
Growth gap
-4.9 pts
Verdict
CHEAP
Discount rate (WACC)
6.00%
Beta
0.34

Behaviour On Record

What CL's own history says about today's numbers

Realized volatility (21d)
27.6% 94th pct
Below its peak
-8.8%
vs 200-day average
+10.4%
Up days (1y)
53%

Colgate-Palmolive Company is currently running 27.6% annualised volatility over the last 21 sessions. Measured against CL's own 13 years of daily returns rather than a market-wide average, that is the 94th percentile — an extreme by its own standards, against a typical reading of 15.9%.

CL is trading -8.8% below its running peak. Across 13 full years on file, its median worst-drawdown-in-a-year was -16.0%, and the deepest was -25.3% in 2018. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +10.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 92nd percentile — a wider gap than this stock usually carries. Over the past year CL closed higher on 53% of sessions, and it is currently 2 sessions into a rising streak.

On November specifically: over 13 years of records, CL finished the month higher 10 of 13 times, with a median return of +3.2% and an average of +2.3%. Its strongest month historically has been November at +2.3% on average, its weakest September at -2.0%.

Overnight risk is measurable too: CL has opened more than 2% away from the prior close in 27 of 3,268 sessions (0.8% of the time), with the largest gaps running +4.7% and -6.4%.

Across the last 4 dated reports on file, CL moved an average of 1.9% in the session after earnings, closing higher 2 of those 4 times, with a median move of +0.5% and a largest of +2.9%.

All figures computed from 3,269 daily closes between 2013-11-06 and 2026-11-05, split-adjusted, recomputed daily. Percentiles are against CL's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of CL's sector?

Colgate-Palmolive Company sits in the Consumer Staples sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#2 of 12
Sector state
Leading
Sector rotation score
82

Options Market

What is the options market pricing for CL?

CallsPuts

For Colgate-Palmolive Company's nearest expiry (2026-11-06, 0 days out), open interest is put-heavy, a defensive/bearish tilt (put/call ratio of 1.74), with at-the-money implied volatility around 39.8%.

Put/call ratio (2026-11-06)
1.74
ATM implied volatility
39.8%
Total open interest
2,880

Analyst Consensus Estimates

What do analysts expect CL to earn?

Analysts expect Colgate-Palmolive Company to earn $3.92 per share in the fiscal year ending Dec 2026 and $4.60 in the fiscal year ending Dec 2029, from 2 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Quarter endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$0.98$0.96 to $1.0213$5.37B13
Mar 2027$0.98$0.93 to $1.0213$5.44B9
Jun 2027$1.04$1.01 to $1.087~$5.60B-
Sep 2027$0.99$0.96 to $1.067~$5.33B-
Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026$3.92$3.88 to $4.0217$21.40B18
Dec 2027$4.09$3.97 to $4.2120$21.91B18
Dec 2028$4.40$4.31 to $4.495~$23.68B-
Dec 2029$4.60$4.58 to $4.612~$24.76B-

Revenue marked ~ is our calculation from the EPS estimate, not analyst consensus.

Analyst Rating Changes

Are analysts turning bullish or bearish on CL?

Barclays most recently reiterated its rating on Colgate-Palmolive Company to Equal-Weight on Nov 3, 2026 with a price target of $95 (from $87). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Barclays: Equal-Weight
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Nov 3, 2026BarclaysMaintainedEqual-Weight$87 → $95
Nov 2, 2026UBSMaintainedBuy$106 → $112
Nov 2, 2026Morgan StanleyMaintainedOverweight$104 → $111
Nov 2, 2026BNP ParibasReiteratedOutperform$97 → $108
Nov 2, 2026TD CowenMaintainedHold$90 → $97
Nov 2, 2026JP MorganMaintainedOverweight$104 → $102
Nov 2, 2026RBC CapitalMaintainedOutperform$104 → $105
Nov 2, 2026Wells FargoMaintainedEqual-Weight$90 → $95
Nov 2, 2026B of A SecuritiesMaintainedBuy$100 → $105
Oct 19, 2026JP MorganMaintainedOverweight$103 → $104
Oct 5, 2026Wells FargoMaintainedEqual-Weight$95 → $90
Sep 21, 2026Piper SandlerMaintainedOverweight$98 → $95

Earnings Release, Scored

What did Colgate-Palmolive Company's latest earnings release say?

Filed Oct 30, 2026 · SEC Form 8-K, Exhibit 99

Tone61.3/ 100-7.3 vs prior release
Hedging words1.02per 100 words+0.53 vs prior release
Tone, last 3 releasesScale 50–74

Most important lines

  1. 1

    We are recognized for our leadership and innovation in promoting community wellbeing and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991.

    New this quarter
  2. 2

    “We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter.

    New this quarter
  3. 3

    The Company now expects organic sales growth to be broadly in line with its nine-month performance (versus 1% to 4% previously).

    New this quarter

Peers & ETF holders

CL peers & ETF holders

News & sentiment

What is the news saying about CL?

CL rose 11.1% over the month to Nov 6. News tone held between 19 and 87 from Oct 6 to Oct 8, then dropped to 24 on Oct 9.

Daily close and news tone, Oct 6 to Nov 6
$90$95$100Oct 6: tone 34Oct 7: tone 19Oct 8: tone 87Oct 9: tone 24Oct 12: tone 54Oct 13: tone 37Oct 14: tone 64Oct 15: tone 69Oct 16: tone 67Oct 19: tone 46Oct 20: tone 45Oct 21: tone 52Oct 22: tone 60Oct 23: tone 38Oct 26: tone 33Oct 27: tone 32Oct 28: tone 55Oct 29: tone 38Oct 30: tone 67Nov 2: tone 60Nov 3: tone 22Nov 4: tone 57Nov 5: tone 50Nov 6: tone 13Oct 6News toneNov 6123
  1. Oct 14 +3.4%same day: Is Colgate-Palmolive (CL) Still A Bargain On Cash Flow?
  2. Oct 23 -3.6%same day: Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
  3. Nov 4 +3.3%same day: Colgate-Palmolive: Improving Execution And A Valuation Discount Make It A Buy

Technical analysis

How strong is CL's momentum right now?

On the daily chart CL ranks at the 57th percentile for momentum against 1,060 stocks and ETFs, a neutral reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling CL?

90 of the 222 tracked managers added to CL in their latest 13F and 126 trimmed. Together they own 66.8% of the company, worth $49.2B. BlackRock and Vanguard Capital Management alone hold 15.1%.

90adding126trimming6unchanged
Largest holders by stake, latest 13FBar = share of CL
  1. $6.4B positionTrimmed 3.8% last quarter
  2. $4.8B positionAdded 0.1% last quarter
  3. $4.3B positionTrimmed 1.5% last quarter
  4. $2.2B positionAdded 0.8% last quarter
  5. $2.1B positionAdded 1.1% last quarter
  6. $2.0B positionAdded 5.7% last quarter
  7. $1.1B positionTrimmed 1.6% last quarter
  8. $1.1B positionTrimmed 1.5% last quarter
  9. $888.0M positionTrimmed 11.2% last quarter
  10. $823.6M positionTrimmed 0.3% last quarter
Full holdings history

Congressional trading

Is Congress trading CL?

8 members of Congress disclosed 18 CL trades between Apr 5, 2018 and Sep 2, 2026: 5 buys and 13 sells, about $144.0K in estimated value.

BuysSells2020202220242026
BuySell$1K–$15K$15K–$50K$50K–$100K$100K–$250K

What stands out

Click one to highlight its trades in the chart

Discover more

How has CL done against its peers?

Over the six months to Nov 6, CL returned +10.0%. Of the 14 related stocks and ETFs, 7 did better, led by EL at +27.7%.

Change since May 6, through Nov 6
−40%−20%0%+20%+40%May 6JunJulAugSepOctNov 6EL +27.7%CL +10.0%PEP −9.2%